Munoz, M. A., Fletcher, E. K., Skinner, O. P., Jurczyluk, J., Kristianto, E., Hodson, M. P., . . . Rogers, M. J. (2021). Bisphosphonate drugs have actions in the lung and inhibit the mevalonate pathway in alveolar macrophages. eLife, 10, . https://doi.org/10.7554/eLife.72430
Chicago Style (17th ed.) CitationMunoz, Marcia A., et al. "Bisphosphonate Drugs Have Actions in the Lung and Inhibit the Mevalonate Pathway in Alveolar Macrophages." ELife 10 (2021). https://doi.org/10.7554/eLife.72430.
MLA (9th ed.) CitationMunoz, Marcia A., et al. "Bisphosphonate Drugs Have Actions in the Lung and Inhibit the Mevalonate Pathway in Alveolar Macrophages." ELife, vol. 10, 2021, https://doi.org/10.7554/eLife.72430.
Warning: These citations may not always be 100% accurate.